Viatris (VTRS) News Today $9.09 +0.11 (+1.22%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VTRS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025June 12 at 4:30 PM | prnewswire.comKuehn Law Encourages Investors of Viatris Inc. to Contact Law FirmJune 10 at 10:41 AM | globenewswire.comVTRS Q1 Earnings Call: Pipeline Advances, Tariff Risks, and Strategic Cost ReviewJune 10 at 10:27 AM | msn.comViatris Inc. (VTRS) Presents at Goldman Sachs 46th Annual Global Healthcare Conference TranscriptJune 9, 2025 | seekingalpha.comGoldman Sachs Initiates Coverage of Viatris (VTRS) with Neutral RecommendationJune 7, 2025 | msn.comViatris (VTRS) Faces Securities Fraud Class Action Over FDA Inspection FalloutJune 6, 2025 | insidermonkey.comViatris Inc. (VTRS) Presents at Jefferies Global Healthcare Conference TranscriptJune 5, 2025 | seekingalpha.comViatris Deadline Today: Rosen Law Firm Urges Viatris Inc. (NASDAQ: VTRS) Stockholders With Large Losses to Contact the Firm for Information About Their RightsJune 3, 2025 | businesswire.comDEADLINE ALERT for VTRS and CGC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of ShareholdersJune 3, 2025 | globenewswire.comVTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJune 2, 2025 | globenewswire.comSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ViatrisJune 2, 2025 | globenewswire.comViatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJune 2, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRSJune 2, 2025 | globenewswire.comVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law FirmJune 2, 2025 | prnewswire.comDEADLINE TOMORROW: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025June 2, 2025 | prnewswire.comVTRS STOCK DEADLINE TOMORROW: Suffer Losses on Viatris Inc.? BFA Law Notifies Investors of Imminent June 3 Securities Class Action Deadline (NASDAQ:VTRS)June 2, 2025 | globenewswire.comViatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast ConditionsJune 2, 2025 | prnewswire.comLost Money on Viatris Inc. (VTRS)? Urged to Join Class Action Before June 3, 2025 - Contact Levi & KorsinskyJune 1, 2025 | markets.businessinsider.comVTRS DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – VTRSJune 1, 2025 | globenewswire.comViatris Deadline: VTRS Investors with Losses in Excess of $100K Have Opportunity to Lead Viatris Inc. Securities Fraud LawsuitJune 1, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRSJune 1, 2025 | prnewswire.comVTRS DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action...May 31, 2025 | markets.businessinsider.comSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ViatrisMay 31, 2025 | prnewswire.comVTRS CLASS NOTICE: Viatris Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS)May 31, 2025 | globenewswire.comDeadline Soon: Viatris Inc. (VTRS) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud LawsuitMay 30, 2025 | businesswire.comViatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights – VTRSMay 30, 2025 | globenewswire.comSHAREHOLDER REMINDER: Berger Montague Reminds Viatris (NASDAQ: VTRS) Investors of the June 3, 2025 DeadlineMay 30, 2025 | globenewswire.comClass Action Filed Against Viatris Inc. (VTRS) - June 3, 2025 Deadline to Join - Contact Levi & KorsinskyMay 30, 2025 | prnewswire.comVTRS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important June 3 Deadline in Securities Class Action – VTRSMay 29, 2025 | globenewswire.comThe Gross Law Firm Notifies Shareholders of Viatris Inc. (VTRS) of a Class Action Lawsuit and an Upcoming DeadlineMay 29, 2025 | globenewswire.comVTRS REMINDER: BFA Law Reminds Viatris Inc. Investors of the Imminent June 3 Deadline in Securities Fraud Class Action (NASDAQ:VTRS)May 29, 2025 | globenewswire.comViatris Q1 Earnings TranscriptMay 29, 2025 | marketbeat.comViatris Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights - VTRSMay 29, 2025 | prnewswire.comKuehn Law Encourages Investors of Viatris Inc. to Contact Law FirmMay 28, 2025 | prnewswire.comVTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMay 28, 2025 | globenewswire.comViatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitMay 28, 2025 | prnewswire.comVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law FirmMay 28, 2025 | prnewswire.comCLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025May 28, 2025 | prnewswire.comVIATRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc. - VTRSMay 27, 2025 | globenewswire.comViatris Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 3, 2025 Deadline to file Lead Plaintiff MotionMay 27, 2025 | globenewswire.comViatris Deadline: VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud LawsuitMay 27, 2025 | prnewswire.comINVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of June 3, 2025 Lead Plaintiff Deadline in the Viatris Inc. (VTRS) Securities Class Action –Investors With Significant Losses Encouraged to Contact the FirmMay 27, 2025 | globenewswire.comViatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitMay 27, 2025 | prnewswire.comDEADLINE NEXT WEEK: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Contact the Firm Before June 3, 2025May 27, 2025 | globenewswire.comVTRS SECURITIES NOTICE: Did Viatris Inc. Commit Securities Fraud? Contact BFA Law about the Class Action Lawsuit by June 3May 27, 2025 | globenewswire.comVIATRIS INC. (NASDAQ: VTRS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Viatris Inc. Investors of Upcoming DeadlineMay 27, 2025 | globenewswire.comVTRS IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – VTRSMay 26, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRSMay 26, 2025 | prnewswire.comVTRS FRAUD: Suffer Losses on Viatris Inc. ...May 25, 2025 | gurufocus.comVTRS FRAUD: Suffer Losses on Viatris Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law (NASDAQ:VTRS)May 25, 2025 | globenewswire.com Get Viatris News Delivered to You Automatically Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address VTRS Media Mentions By Week VTRS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VTRS News Sentiment▼0.000.87▲Average Medical News Sentiment VTRS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VTRS Articles This Week▼710▲VTRS Articles Average Week Get Viatris News Delivered to You Automatically Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Genmab A/S News Intra-Cellular Therapies News Dr. Reddy's Laboratories News Moderna News Ascendis Pharma A/S News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VTRS) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viatris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viatris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
